Cortisol Decreases Hepatocyte Growth Factor Levels in Human Osteoblast-Like Cells

[1]  E. Canalis,et al.  Fibroblast growth factor-2 induces hepatocyte growth factor/scatter factor expression in osteoblasts. , 1999, Endocrinology.

[2]  J. Jansson,et al.  Insulin-Like Growth Factors Stimulate Expression of Hepatocyte Growth Factor But Not Transforming Growth Factor β1 in Cultured Hepatic Stellate Cells. , 1997, Endocrinology.

[3]  D. Dempster,et al.  Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. , 1997, The Journal of endocrinology.

[4]  K. Chihara,et al.  Dexamethasone Stimulates Osteoclast‐like Cell Formation by Directly Acting on Hemopoietic Blast Cells and Enhances Osteoclast‐like Cell Formation Stimulated by Parathyroid Hormone and Prostaglandin E2 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  K. Matsumoto,et al.  Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. , 1997, Blood.

[6]  B. Kream,et al.  Dexamethasone suppresses in vivo levels of bone collagen synthesis in neonatal mice. , 1997, Bone.

[7]  J. Jansson,et al.  Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells. , 1997, Endocrinology.

[8]  S. Ljunghall,et al.  Insulin-like Growth Factor I Does Not Stimulate Bone Resorption in Cultured Neonatal Mouse Calvarial Bones , 1996, Calcified Tissue International.

[9]  U. Lerner,et al.  Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  E. Canalis.  Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. , 1996, The Journal of clinical endocrinology and metabolism.

[11]  R. Altman,et al.  Hepatocyte growth factor and its actions in growth plate chondrocytes. , 1996, Bone.

[12]  E. Jimi,et al.  Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. , 1996, Endocrinology.

[13]  A. Zallone,et al.  Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Ohlsson,et al.  Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. , 1996, The Journal of endocrinology.

[15]  K. Matsumoto,et al.  Emerging multipotent aspects of hepatocyte growth factor. , 1996, Journal of biochemistry.

[16]  K. Chihara,et al.  Prostaglandin E2 stimulates osteoclast‐like cell formation and bone‐resorbing activity via osteoblasts: Role of cAMP‐dependent protein kinase , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  C. Ohlsson,et al.  Expression of functional growth hormone receptors in cultured human osteoblast-like cells. , 1995, The Journal of clinical endocrinology and metabolism.

[18]  T. Martin,et al.  Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors , 1995, The Journal of experimental medicine.

[19]  T. Chambers,et al.  The effect of hepatocyte growth factor on the behaviour of osteoclasts. , 1995, Biochemical and biophysical research communications.

[20]  P. Lollini,et al.  The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. , 1995, Oncogene.

[21]  T. Martin,et al.  Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity , 1994, Journal of cellular biochemistry.

[22]  T. Suda.  Modulation of osteoclast differentiation [published erratum appears in Endocr Rev 1992 May;13(2):191] , 1992 .

[23]  E. Gherardi,et al.  Hepatocyte growth factor--scatter factor: mitogen, motogen, and met. , 1991, Cancer cells.

[24]  G. Gronowicz,et al.  Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  R. Bockman,et al.  Steroid-induced osteoporosis. , 1990, The Orthopedic clinics of North America.

[26]  J. Tobias,et al.  Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. , 1989, Endocrinology.

[27]  T. Martin,et al.  Osteoblastic cells are involved in osteoclast formation. , 1988, Endocrinology.

[28]  R. Jilka.  Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone? , 1986, Bone and mineral.

[29]  T. Nakamura,et al.  Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. , 1984, Biochemical and biophysical research communications.